See more : Talwalkars Healthclubs Limited (TALWGYM.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Acadia Healthcare Company, Inc. (ACHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Acadia Healthcare Company, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Federal National Mortgage Association (FNMAP) Income Statement Analysis – Financial Results
- Datatec Limited (DTTLY) Income Statement Analysis – Financial Results
- Super Group (SGHC) Limited (SGHC) Income Statement Analysis – Financial Results
- Chevalier International Holdings Limited (0025.HK) Income Statement Analysis – Financial Results
- PDX Partners, Inc. (PDXP) Income Statement Analysis – Financial Results
Acadia Healthcare Company, Inc. (ACHC)
About Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.93B | 2.61B | 2.31B | 2.09B | 3.11B | 3.01B | 2.84B | 2.81B | 1.79B | 1.00B | 713.41M | 407.46M | 221.37M | 62.10M |
Cost of Revenue | 2.25B | 1.49B | 1.33B | 1.24B | 1.84B | 1.78B | 1.65B | 1.66B | 1.05B | 623.83M | 445.53M | 259.14M | 167.94M | 42.36M |
Gross Profit | 682.61M | 1.12B | 979.89M | 848.17M | 1.27B | 1.23B | 1.19B | 1.15B | 740.10M | 380.77M | 267.88M | 148.33M | 53.44M | 19.74M |
Gross Profit Ratio | 23.31% | 42.78% | 42.34% | 40.58% | 40.78% | 40.96% | 41.80% | 40.97% | 41.24% | 37.90% | 37.55% | 36.40% | 24.14% | 31.79% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 176.01M | 203.48M | 175.26M | 157.85M | 323.21M | 307.71M | 273.00M | 258.83M | 148.99M | 64.68M | 47.22M | 26.86M | 57.74M | 3.08M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 176.01M | 203.48M | 175.26M | 157.85M | 323.21M | 307.71M | 273.00M | 258.83M | 148.99M | 64.68M | 47.22M | 26.86M | 57.74M | 3.08M |
Other Expenses | 0.00 | 445.60M | 390.16M | 357.53M | 539.48M | -34.51M | -24.27M | -48.32M | -36.57M | -13.65M | -7.15M | -8.11M | 24.76M | -918.00K |
Operating Expenses | 176.01M | 649.07M | 565.41M | 515.38M | 862.69M | 821.04M | 747.84M | 706.49M | 419.29M | 208.00M | 144.88M | 77.62M | 82.50M | 10.93M |
Cost & Expenses | 2.42B | 2.14B | 1.90B | 1.76B | 2.70B | 2.60B | 2.40B | 2.37B | 1.47B | 831.84M | 590.41M | 336.75M | 250.44M | 53.29M |
Interest Income | 0.00 | 69.76M | 76.99M | 158.11M | 187.33M | 876.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 82.13M | 69.76M | 76.99M | 158.11M | 187.09M | 185.41M | 176.01M | 181.33M | 106.74M | 48.22M | 37.25M | 29.77M | 9.19M | 738.00K |
Depreciation & Amortization | 132.35M | 117.77M | 106.72M | 95.26M | 87.92M | 158.83M | 143.01M | 135.10M | 63.55M | 32.67M | 17.09M | 7.98M | 4.29M | 976.00K |
EBITDA | 189.11M | 561.67M | 459.47M | 437.16M | 402.02M | 385.88M | 580.89M | 580.25M | 384.36M | 205.43M | 140.09M | 70.58M | -24.78M | 8.87M |
EBITDA Ratio | 6.46% | 21.52% | 22.52% | 22.05% | 18.30% | 18.97% | 20.48% | 20.64% | 21.42% | 20.45% | 19.64% | 19.31% | -11.19% | 14.29% |
Operating Income | 506.60M | 443.90M | 414.47M | 365.61M | 404.53M | 412.74M | 437.88M | 445.14M | 320.81M | 172.76M | 123.00M | 70.71M | -29.07M | 8.81M |
Operating Income Ratio | 17.30% | 17.01% | 17.91% | 17.49% | 13.02% | 13.70% | 15.44% | 15.84% | 17.88% | 17.20% | 17.24% | 17.35% | -13.13% | 14.19% |
Total Other Income/Expenses | -531.96M | -72.10M | -120.81M | -148.99M | -235.70M | -581.70M | -201.08M | -412.19M | -156.06M | -46.61M | -53.75M | -37.88M | -5.38M | -1.66M |
Income Before Tax | -25.36M | 374.14M | 275.76M | 183.80M | 135.99M | -168.95M | 236.80M | 32.96M | 164.75M | 126.15M | 69.25M | 32.83M | -38.26M | 7.16M |
Income Before Tax Ratio | -0.87% | 14.33% | 11.91% | 8.79% | 4.38% | -5.61% | 8.35% | 1.17% | 9.18% | 12.56% | 9.71% | 8.06% | -17.28% | 11.53% |
Income Tax Expense | -9.70M | 94.11M | 67.56M | 40.61M | 25.87M | 6.53M | 37.21M | 28.78M | 46.40M | 42.92M | 25.98M | 12.33M | -5.38M | 477.00K |
Net Income | -21.67M | 273.14M | 190.64M | 143.19M | 108.92M | -175.75M | 199.84M | 6.14M | 119.55M | 83.04M | 42.58M | 20.40M | -34.89M | 6.21M |
Net Income Ratio | -0.74% | 10.46% | 8.24% | 6.85% | 3.51% | -5.83% | 7.05% | 0.22% | 6.66% | 8.27% | 5.97% | 5.01% | -15.76% | 10.00% |
EPS | -0.24 | 3.05 | 2.30 | 1.63 | 1.24 | -2.01 | 2.30 | 0.07 | 1.75 | 1.51 | 0.85 | 0.53 | -1.86 | 0.35 |
EPS Diluted | -0.24 | 2.98 | 2.25 | 1.62 | 1.24 | -2.01 | 2.30 | 0.07 | 1.75 | 1.50 | 0.85 | 0.53 | -1.86 | 0.35 |
Weighted Avg Shares Out | 90.95M | 89.68M | 88.77M | 87.88M | 87.61M | 87.29M | 86.95M | 85.70M | 68.09M | 55.06M | 50.00M | 38.48M | 18.76M | 17.63M |
Weighted Avg Shares Out (Dil) | 90.95M | 91.56M | 90.79M | 88.60M | 87.82M | 87.29M | 87.06M | 85.97M | 68.39M | 55.33M | 50.26M | 38.70M | 18.76M | 17.63M |
Lead Plaintiff Deadline Approaching in ACHC: Kessler Topaz Meltzer & Check, LLP Reminds Investors A Securities Fraud Class Action Has Been Filed Against Acadia Healthcare Company, Inc.
The Schall Law Firm Encourages Shareholder Participation In A Fraud Case Against Acadia Healthcare Company Inc
ACHC Investors Have Opportunity to Lead Acadia Healthcare Company, Inc. Securities Fraud Lawsuit with the SLF
ACHC STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Acadia Healthcare Company, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Acadia Healthcare (ACHC) Class Period Expanded After NYT Report That Veterans Affairs Department Is Investigating Allegations of Holding Patients Longer Than Is Medically Necessary – Hagens Berman
ACHC LEGAL UPDATE: BFA Law has Filed a Lawsuit Against Acadia Healthcare for Securities Fraud - Contact the Firm before Court Deadline (Nasdaq:ACHC)
ACHC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Acadia Healthcare Company, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
ACADIA HEALTHCARE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc. - ACHC
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Acadia Healthcare Company, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ACHC
ACHC LEGAL NOTICE: BFA Law Reminds Acadia Healthcare Investors with Losses to Contact the Firm before December 16 Court Deadline
Source: https://incomestatements.info
Category: Stock Reports